Elizabeth Douville

Life sciences executive

Montreal, Quebec

Investor

Founder

Invests in

Stages:

Sectors:

Locations:

Min Investment:
$100,000.00
Max Investment:
$5,000,000.00
Target Investment:
$1,500,000.00

Skills

Biotechnology

Technology Transfer

Venture Capital

Lifesciences

Mergers & Acquisitions

Commercialization

Investments

Portfolio Management

Drug Development

Drug Discovery

Pharmaceutical Industry

Intellectual Property

Management

Clinical Development

Patents

Corporate Development

Biopharmaceuticals

Life Sciences

Education

ICD-Rotman, Directors Education Program
Institute of Corporate Directors
(2022 - 2023)
CIREM-HEC Certificate
HEC Montréal
(2008 - 2008)
PhD
University of Ottawa
(1989 - 1994)
Postdoctoral internship
Imperial Cancer Research Fund
(1994 - 1997)
Bachelor
McGill University
(1984 - 1987)

Investments

Inversago Pharma

Series A

Total Funding: $110M

Semathera

Series Unknown

Total Funding: $3M

Alethia BioTherapeutics

Series A

Total Funding: $16M

Work Experience

Centre de production de produits biologiques (CPPB) inc. / Biologics Manufacturing Centre (BMC) Inc.

2024

Board Member
2024

IRICoR

2023

President & CEO
2023

AmorChem

2011

Founder
2011
AmorChem is a leading early-stage venture capital investing in research innovation and creating next-gen biotech companies in life sciences. The fund has 95M$ under management for pre-seed, seed and Series A investments.

Genome Canada

2016